Therapeutic Targets in Triple Negative Breast Cancer - Where are we now?

E-ISSN： 2212-3970|6|2|196-209

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.6, Iss.2, 2011-05, pp. : 196-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer

Oncology Letters, Vol. 3, Iss. 1, 2012-01 ,pp. : 163-171

Spandidos Publications

Access to resources Recommend Favorite

The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in Breast Cancer: Where Are We Now?

By McLaughlin Sarah Mittendorf Elizabeth Bleicher Richard McCready David King Tari

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 28-36

Springer Publishing Company

Access to resources Recommend Favorite

Development of targeted therapies for triple-negative breast cancer: can we harness tumor heterogeneity to improve patient outcomes?

By Diamond Jennifer R Elias Anthony D

Breast Cancer Management, Vol. 2, Iss. 3, 2013-05 ,pp. : 175-178

Future Medicine

Access to resources Recommend Favorite

Imaging findings of triple-negative breast cancer

By Kawashima Hiroko

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 145-145

Springer Publishing Company

Access to resources Recommend Favorite

MR imaging of triple-negative breast cancer

By Uematsu Takayoshi

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 161-164

Springer Publishing Company

Access to resources Recommend Favorite